BioLamina offers an expansive portfolio of human recombinant laminin proteins for a variety of applications. With their cell therapy grade products, they can support scientists throughout their cell therapy development process – from concept to commercialized therapy. Their Biolaminin substrates are defined, full-length laminin cell culture matrices that can be used for a variety of applications. For example, these are used for the expansion of human pluripotent stem cells and differentiation and maintenance of different specialized cell types, such as hepatocytes, cardiomyocytes, and neural cells.
BioLamina is a Swedish biotechnology company with a global presence and their laminin technology has been scientifically validated in many high impact journals.
Bio-Connect supplies all
BioLamina products in the Benelux. If you have any questions, please contact the
helpdesk.
BioLamina products
| CT521-0501 | Biolaminin 521 CTG | 500 ug |
| MX521-0501 | Biolaminin 521 MX | 500 ug |
| LN521-02 | Biolaminin 521 LN | 100 ug |
| LN511-0202 | Biolaminin 511 LN | 100 ug |
| LN421-02 | Biolaminin 421 LN | 100 ug |
| LN411-02 | Biolaminin 411 LN | 100 ug |
| LN332-0202 | Biolaminin 332 LN | 100 ug |
| LN221-02 | Biolaminin 221 LN | 100 ug |
| LN211-02 | Biolaminin 211 LN | 100 ug |
| LN121-02 | Biolaminin 121 LN | 100 ug |
| LN111-02 | Biolaminin 111 LN | 100 ug |
| LNKT-0201 | LAMscreen | 400 ug |
| BS521-0101 | Biosilk 521 | 752 ug |
| BS-0101 | Biosilk | 750 ug |
Major product lines
- Defined and xeno-free laminin-based cell culture matrices
- Animal stem cells
- Cancer cells
- Cardiac applications
- Clonal applications
- Endothelial applications
- Epithelial applications
- Expansion of human PSC
- Eye applications
- Hepatic applications
- Intestinal applications
- Kidney cell culture
- Lung applications
- Neural applications
- Pancreatic applications
- Skeletal muscle applications
BioLamina news
For more information, please visit:
www.biolamina.com
